TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin

被引:113
|
作者
Vijay-Kumar, Matam [1 ]
Carvalho, Frederic A. [1 ]
Aitken, Jesse D. [1 ]
Fifadara, Nimita H. [1 ]
Gewirtz, Andrew T. [1 ]
机构
[1] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA
关键词
Antibodies; IL-18; Innate immunity; NF-kappa B; NLRC4; TOLL-LIKE RECEPTOR-5; INTERLEUKIN-1-BETA; CASPASE-1; CELLS; ACTIVATION; SECRETION; IPAF;
D O I
10.1002/eji.201040421
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The fact that some TLR-based vaccine adjuvants maintain function in TLR-deficient hosts highlights that their mechanism of function remains incompletely understood. Thus, we examined the ability of flagellin to induce cytokines and elicit/promote murine antibody responses upon deletion of the flagellin receptors TLR5 and/or NLRC4 (also referred to as IPAF) using a prime/boost regimen. In TLR5-KO mice, flagellin failed to induce NF-kappa B-regulated cytokines such as keratinocyte-derived chemokine (CXCL1) but induced WT levels of the inflammasome cytokine IL-18 (IL-1F4). Conversely, in NLRC4-KO mice, flagellin induced keratinocyte-derived chemokine, but not IL-18, whereas TLR5/NLRC-4DKO lacked induction of all cytokines measured. Flagellin/ovalbumin treatment resulted in high-antibody titers to both flagellin and ovalbumin in WT, TLR5-KO and DKO mice but did not elicit antibodies to either in TLR5/NLRC4-DKO mice. Thus, flagellin's ability to elicit/promote humoral immunity requires a germ-line-encoded receptor capable of recognizing this molecule. Such promotion of adaptive immunity can be effectively driven by either TLR5-mediated activation of NF-kappa B or NLRC4-mediated activation of the inflammasome.
引用
收藏
页码:3528 / 3534
页数:7
相关论文
共 50 条
  • [32] An arginine residue in flagellin as the hot spot of TLR5 binding and activation
    Song, W. S.
    Jeon, Y. J.
    Namgung, B.
    Hong, M.
    Yoon, S. I.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2017, 46 : S175 - S175
  • [33] Detection of flagellin by interaction with human recombinant TLR5 immobilized in liposomes
    Olguin, Y.
    Villalobos, P.
    Carrascosa, L. G.
    Young, M.
    Valdez, E.
    Lechuga, L.
    Galindo, R.
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2013, 405 (04) : 1267 - 1281
  • [34] Structural Basis of Conserved Flagellin-mediated TLR5 Stimulation
    Song, Wan Seok
    Jeon, Ye Ji
    Namgung, Byeol
    Hong, Minsun
    Yoon, Sung-il
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2018, 74 : A190 - A190
  • [35] Structural engineering of flagellin as vaccine adjuvant: quest for the minimal domain of flagellin for TLR5 activation
    Afzal, Haroon
    Murtaza, Asad
    Cheng, Li-Ting
    MOLECULAR BIOLOGY REPORTS, 2025, 52 (01)
  • [36] Detection of flagellin by interaction with human recombinant TLR5 immobilized in liposomes
    Y. Olguín
    P. Villalobos
    L. G. Carrascosa
    M. Young
    E. Valdez
    L. Lechuga
    R. Galindo
    Analytical and Bioanalytical Chemistry, 2013, 405 : 1267 - 1281
  • [37] TLR5 Is Not Required for Flagellin-mediated Exacerbation of DSS Colitis
    Ivison, Sabine M.
    Himmel, Megan E.
    Hardenberg, Gijs
    Wark, Paige A. J.
    Kifayet, Arnawaz
    Levings, Megan K.
    Steiner, Theodore S.
    INFLAMMATORY BOWEL DISEASES, 2010, 16 (03) : 401 - 409
  • [38] TLR5 Signaling in the Regulation of Intestinal Mucosal Immunity
    Feng, Shuyan
    Zhang, Chi
    Chen, Shanshan
    He, Ruonan
    Chao, Guanqun
    Zhang, Shuo
    JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 2491 - 2501
  • [39] Flagellin Within Pseudomonas AerugINOSa Induce Neutrophil Pyroptosis Through Nlrc4 Inflammasome Activation
    Ryu, J-H
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [40] NLRC4 Inflammasome-Driven Immunogenicity of a Recombinant MVA Mucosal Vaccine Encoding Flagellin
    Sanos, Stephanie L.
    Kassub, Ronny
    Testori, Marco
    Geiger, Marlene
    Patzold, Juliane
    Giessel, Raphael
    Knallinger, Johanna
    Bathke, Barbara
    Graebnitz, Fabienne
    Brinkmann, Kay
    Chaplin, Paul
    Suter, Mark
    Hochrein, Hubertus
    Lauterbach, Henning
    FRONTIERS IN IMMUNOLOGY, 2018, 8